Isoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022
April 29 2022 - 8:05AM
Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology
company and innovator in seed brachytherapy, today announced that
it will host a conference call to discuss its financial results for
the third quarter fiscal 2022 ended March 31, 2022 on Tuesday, May
10, 2022, at 4:30 p.m. Eastern Time. The Company will issue a press
release announcing its financial results for the third quarter
fiscal year 2022 after the close of the U.S. stock markets on
Tuesday, May 10, 2022.
To listen to the conference call, please dial (888) 506-0062.
For callers outside the U.S., please dial (973) 528-0011.
The conference call will be simultaneously webcast and can be
accessed at https://www.webcaster4.com/Webcast/Page/2199/45391. The
webcast will be available until August 10, 2022 following the
conference call.
About
IsorayIsoray, Inc. is a
medical technology company pioneering advanced treatment
applications and devices to deliver targeted internal radiation
treatments for cancers throughout the body. Isoray, Inc., through
its subsidiary, Isoray Medical, Inc., is the sole producer of
Cesium-131 brachytherapy seeds. Learn more about this innovative
Richland, Washington company and explore the many benefits and uses
of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and
Twitter.
Contact
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
IsoRay (AMEX:ISR)
Historical Stock Chart
From Apr 2024 to May 2024
IsoRay (AMEX:ISR)
Historical Stock Chart
From May 2023 to May 2024